UK markets closed

Intech Biopharm Corporation (6461.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
27.10-0.15 (-0.55%)
At close: 01:30PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-337,987
-337,987
-327,877
-301,756
-250,370
Depreciation & amortisation
84,811
84,811
85,355
85,296
84,946
Stock-based compensation
14,125
14,125
16,886
10,635
4,296
Change in working capital
5,277
5,277
13,578
-14,534
-22,476
Inventory
9,363
9,363
6,552
-4,268
-12,557
Other working capital
-234,340
-234,340
-201,389
-221,912
-215,537
Other non-cash items
29,210
29,210
21,120
18,683
16,089
Net cash provided by operating activities
-204,133
-204,133
-190,389
-200,606
-167,378
Cash flows from investing activities
Investments in property, plant and equipment
-30,207
-30,207
-11,000
-21,306
-48,159
Purchases of investments
-210,000
-210,000
-195,000
-15,000
0
Sales/maturities of investments
-
-
-
0
5,000
Other investing activities
-
-
65
-60
231
Net cash used for investing activities
-235,978
-235,978
-203,976
-35,518
-42,205
Net change in cash
12,910
12,910
-155,662
15,796
32,565
Cash at beginning of period
64,819
64,819
220,481
204,685
172,120
Cash at end of period
77,729
77,729
64,819
220,481
204,685
Free cash flow
Operating cash flow
-204,133
-204,133
-190,389
-200,606
-167,378
Capital expenditure
-30,207
-30,207
-11,000
-21,306
-48,159
Free cash flow
-234,340
-234,340
-201,389
-221,912
-215,537